Chromatin modifying complexes Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۴۶-۶۰ از ۲۰۱ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Ageliki Tsagaratouمشاهده پروفایل

استادیار

University of North Carolina at Chapel HillUnited States

Dr. Ageliki Tsagaratou is an Assistant Professor in the Department of Genetics at the University of North Carolina at Chapel Hill School of Medicine, where she leads the Tsagaratou Lab focused on epigenetic mechanisms in immune cell development. Her research program investigates how TET family proteins regulate DNA demethylation and transcriptional networks during T cell differentiation in the thymus and periphery. Her primary research interests include: Epigenetic regulation of T cell lineage specification DNA demethylation mechanisms mediated by TET proteins (TET1, TET2, TET3) Role of 5-hydroxymethylcytosine in immune cell development Mechanisms linking epigenetic dysregulation to autoimmunity and hematological malignancies Transcriptional control of invariant natural killer T cell development Dr. Tsagaratou's laboratory employs genetically modified mouse models, primary cell culture, multiparameter flow cytometry, molecular biology assays, and next-generation sequencing technologies to elucidate epigenetic regulatory mechanisms. Recent publications demonstrate her team's focus on TET protein functions in T cell receptor repertoire formation, T follicular helper cell biology, and malignant transformation pathways. As a mentor, she emphasizes individualized development plans, daily communication, and collaborative problem-solving. Her lab participates in interdisciplinary seminars at UNC's Comprehensive Lineberger Cancer Center and Carolina Chromatin Consortium. The laboratory is located in the Burnett-Womack Building on UNC's Chapel Hill campus.

پروفایل رسمی دانشگاه

Ralitza H. Gavrilovaمشاهده پروفایل

استاد

Mayo Clinic College of Medicine and ScienceUnited States

Ralitza H. Gavrilova, MD, is a Professor of Neurology and Professor of Medical Genetics at Mayo Clinic College of Medicine. She holds primary appointment as Consultant in the Department of Medical Genetics and joint appointment as Consultant in the Section of Multiple Sclerosis, Department of Neurology at Mayo Clinic in Rochester, Minnesota. Dr. Gavrilova serves as Director of the Mayo Clinic Mitochondrial Care Center and holds leadership roles in several professional organizations including the United Mitochondrial Disease Foundation, Mitochondrial Medicine Society, and North American Mitochondrial Disease Consortium. Dr. Gavrilova completed her medical education at Medical University - Sofia, followed by residency training in Neurology at the University of Missouri, Columbia, and specialized fellowship training in Medical Genetics at Mayo Clinic. She is board certified in Neurology by the American Board of Psychiatry and Neurology. Her research focuses on mitochondrial medicine and neurogenetics, with particular expertise in mitochondrial myopathy, multisystemic mitochondrial diseases, Friedreich's ataxia, neurodegenerative conditions involving mitochondrial dysfunction, and hereditary leukodystrophies. Dr. Gavrilova's research goal is to improve understanding of mitochondrial dysfunction in disease to develop better diagnostic approaches, evaluation methods, and new therapies for patients. With over 100 publications spanning from 2002 to 2025, Dr. Gavrilova's work demonstrates increasing research productivity in recent years. Her publications cover diverse topics in neurogenetics, mitochondrial disorders, leukodystrophies, and frontotemporal lobar degeneration, reflecting her broad expertise in neurological genetic conditions. First award winning poster presentation, International Multiple Sclerosis meeting ECTRIMS, Prague (2007) Plenary Session Presentation, American Academy of Neurology 58th annual meeting (2006) Daniel M. Keniston Award for Outstanding Resident, University of Missouri School of Medicine (2001) Medical Academy Scholarship (top 1% of class) (1985) Dr. Gavrilova actively supervises research through her role as Director of the Mayo Clinic Mitochondrial Care Center and serves as Principal Investigator for the Mayo Clinic patient registry site of the North American Mitochondrial Disease Consortium. She has held leadership positions including Clinical Director of the Foundation for Angelman Syndrome Therapeutics and Clinical Director of the Angelman Syndrome Foundation. As Director of the Mayo Clinic Mitochondrial Care Center, Dr. Gavrilova leads a specialized team focused on diagnosing and treating mitochondrial disorders, conducting clinical research, and developing new therapeutic approaches for patients with these complex conditions.

پروفایل رسمی دانشگاه

Nicolas Gévryمشاهده پروفایل

استاد

University of SherbrookeCanada

Nicolas Gévry is a Professor in the Department of Biology at the University of Sherbrooke, specializing in molecular and cellular biology with a focus on nuclear receptor signaling pathways and chromatin dynamics in endocrine systems. His educational credentials include: M.Sc. in Molecular Biology from Université de Montréal (2000) Ph.D. in Molecular Biology/Veterinary Sciences from Université de Montréal (2003) Postdoctoral training at Cornell University and University of Sherbrooke Dr. Gévry's research centers on transcriptional regulation by nuclear receptors, particularly estrogen and androgen receptors, examining how chromatin remodeling complexes and histone modifications control gene expression in physiological and pathological contexts. His work bridges molecular mechanisms with clinical applications in breast cancer, infertility, and ovarian function, emphasizing the role of epigenetic regulators like H2A.Z and JMJD3 in hormone-dependent diseases. Analysis of his 2009-2011 publications reveals a cohesive research trajectory exploring histone variant dynamics in nuclear receptor signaling, with consistent focus on breast cancer models and transcriptional control mechanisms. The work demonstrates how chromatin architecture dictates hormonal response specificity and identifies potential therapeutic targets for endocrine-related pathologies. Dr. Gévry leads an active research laboratory investigating the molecular interplay between nuclear receptors, chromatin modifiers, and transcriptional machinery. His team employs biochemical, genomic, and cell-based approaches to dissect mechanisms underlying ovarian physiology and hormone-responsive cancers, maintaining collaborations with institutions like Cornell University and clinical researchers in oncology.

پروفایل رسمی دانشگاه

Roderick Dashwoodمشاهده پروفایل

استاد

Texas A&M UniversityUnited States

Roderick Dashwood is the Director of the Center for Epigenetics & Disease Prevention and a Professor in the Department of Translational Medical Sciences at Texas A&M University School of Medicine. His research focuses on epigenetic mechanisms in cancer prevention, particularly colorectal cancer, leveraging dietary agents and immunomodulatory therapies. He leads translational studies integrating epigenetic regulation, drug combinations (e.g., erlotinib/sulindac), and biomarker discovery. Key research areas include: Epigenetic targeting of histone modifiers (e.g., PRC2 complexes, bromodomain proteins) Immunogenicity modulation in gastrointestinal malignancies Role of dietary polyphenols (e.g., sulforaphane, mango polyphenols) in inflammation and cancer Mechanisms of chemosensitization and drug synergy Recent work highlights the antitumor efficacy of low-dose erlotinib/sulindac combinations and the impact of neonatal inflammation on adult colitis. His publications emphasize translational advances, including metabolomic profiling and microbiome interactions in cancer models. Labs/Teams: Directs the Center for Epigenetics & Disease Prevention, collaborating with Texas A&M AgriLife Research and the Texas A&M Health Science Center.

پروفایل رسمی دانشگاه

Maria Christophorouمشاهده پروفایل

استادیار

University of CambridgeUnited Kingdom

Maria Christophorou is a Tenure Track Group Leader at the Cambridge Stem Cell Institute and the Epigenetics Department at the Babraham Institute, University of Cambridge. She leads the Christophorou Group which focuses on understanding how developmental cues and cellular stresses are translated into epigenetic changes through the biochemical regulation of epigenetic factors, with particular emphasis on PADI enzymes and protein citrullination. Her research integrates biochemistry, cell and molecular biology, genomic and epigenetic approaches, and mouse model systems to investigate the mechanisms that modulate epigenetic regulators in health and disease. Dr. Christophorou's research expertise centers on protein citrullination, a post-translational modification that converts arginine residues to citrulline. Her work explores how peptidylarginine deiminases (PADI enzymes) regulate chromatin structure, pluripotency, and cellular responses to stress. She has made significant contributions to understanding the role of PADI4 in stem cell biology, the evolutionary origins of citrullination, and the implications of dysregulated citrullination in autoimmunity, neurodegeneration, and cancer. Her interdisciplinary approach bridges molecular mechanisms with physiological outcomes, revealing how epigenetic regulation shapes cellular identity and function during development and disease. Her recent publications demonstrate a strong focus on developing tools to study PADI enzymes, creating comprehensive maps of citrullination sites across the proteome, and investigating the evolutionary history of citrullination. The research shows progression from fundamental mechanistic studies toward translational applications, particularly in understanding how citrullination contributes to autoimmune diseases like rheumatoid arthritis and potential therapeutic targeting of PADI enzymes. Sir Henry Dale Fellow (Wellcome Trust and Royal Society) Wellcome-Beit Prize recipient EMBO Long-Term Postdoctoral Fellowship HFSP Long-Term Postdoctoral Fellowship Chancellor's Fellowship at University of Edinburgh Dr. Christophorou actively mentors PhD students, postdoctoral researchers, and visiting scientists in her laboratory. Her group has secured significant funding including the Sir Henry Dale Fellowship from the Wellcome Trust and Royal Society, supporting research into the biochemical regulation of epigenetic factors. She has successfully guided multiple students through PhD completion, with alumni now in positions at research institutions including the MRC Human Genetics Unit, Oxford University, and industry roles. The Christophorou Group operates within the Epigenetics Programme at the Babraham Institute and maintains strong connections with the Cambridge Stem Cell Institute. The laboratory employs a multidisciplinary team of researchers with expertise spanning biochemistry, proteomics, cell biology, and computational analysis to investigate the complex roles of protein citrullination in cellular physiology and disease mechanisms.

پروفایل رسمی دانشگاه

Peter S. Kleinمشاهده پروفایل

استاد

University of PennsylvaniaUnited States

Peter S. Klein is a Professor of Medicine (Hematology-Oncology) at the Perelman School of Medicine, University of Pennsylvania. He holds multiple leadership roles including Director of the Physician-Scientist Pathway in the Department of Medicine, Vice-chief for Research in Hematology-Oncology, and member of the Abramson Cancer Center and David Mahoney Institute of Neurological Sciences. Dr. Klein serves as an attending physician in the Division of Hematology-Oncology at the Hospital of the University of Pennsylvania and advises the MD/PhD program. Dr. Klein received his B.A. in Biochemistry from Harvard College in 1980, followed by his M.D. and Ph.D. in Biological Chemistry from Johns Hopkins University School of Medicine in 1988. Dr. Klein's research spans several interconnected areas focused on understanding fundamental biological processes and their implications for human disease. His laboratory investigates: Wnt signaling and chromatin modifications in early vertebrate development Regulation of hematopoietic and neural stem cell self-renewal Molecular mechanisms of lithium action in bipolar disorder Role of GSK-3 in stem cell biology and cancer His work bridges developmental biology, stem cell research, and translational medicine, with particular emphasis on how basic molecular pathways can be targeted for therapeutic applications in cancer and neuropsychiatric disorders. Analysis of Dr. Klein's recent publications reveals a consistent focus on Wnt signaling pathways, stem cell biology, and the therapeutic applications of GSK-3 inhibition. His research spans from fundamental developmental biology (studying Wnt signaling in Xenopus embryos) to translational applications in hematopoietic stem cell expansion and cancer therapeutics. A significant thread throughout his work is the investigation of lithium's mechanism of action through GSK-3 inhibition, connecting his basic research to clinical applications in bipolar disorder. His laboratory has made important contributions to understanding how chromatin architecture is modified by Wnt signaling, how GSK-3 regulates hematopoietic stem cell self-renewal, and the neural mechanisms underlying mood disorder treatments. Dr. Klein leads an active research laboratory with multiple postdoctoral fellows, graduate students, and research specialists. His lab employs a diverse array of techniques including molecular analysis of chromatin structure, biochemical analysis of signaling pathways, mouse models, and ex vivo stem cell culture systems. He is actively involved in training the next generation of physician-scientists through his role as Director of the Physician-Scientist Pathway and as an MD/PhD program adviser.

پروفایل رسمی دانشگاه

Chinmay Trivediمشاهده پروفایل

استاد

University of Massachusetts Chan Medical SchoolUnited States

Dr. Chinmay Trivedi is a Professor of Medicine at UMass Chan Medical School , with additional affiliations in Molecular, Cell and Cancer Biology, and Translational Science programs. His research focuses on elucidating chromatin-modifying mechanisms in congenital cardiovascular and lymphatic diseases. Director, Division of Cardiovascular Medicine Research Research Director, Translational Science Program (Morningside Graduate School) Principal Investigator in Trivedi Lab Research Highlights: His laboratory established causal links between: Hdac3 mutations and Emberger syndrome (lymphedema) through non-coding DNA element analysis KRAS/BRAF mutations and hepatic vascular cavernomas with RAS-MAPK1 pathway inhibition as treatment Hdac1/Hdac2 roles in cryptic transcription suppression during cardiogenesis Tbx5-Hdac3 interactions in Holt-Oram syndrome pathogenesis YAP1 activation in vascular tumor epithelioid hemangioendothelioma Publication Trends show consistent work across Journal of Clinical Investigation , Science Advances , and Circulation Research , with recent emphasis on: Epigenetic regulation of cardiovascular development Signaling pathway modulation in lymphatic diseases Translational models for congenital defects Metabolic basis of cardiac pathologies Training Opportunities: The lab offers rotation projects for graduate students and postdoctoral positions requiring expertise in: Murine models ChIP-seq and epigenetic analysis Biochemical signaling assays Translational biology techniques Key Concepts: Histone deacetylases, non-coding DNA, RAS-MAPK1 pathway, oscillatory shear stress, cryptic transcription, enhanceosome complexes

پروفایل رسمی دانشگاه

Lindsay Mehrmaneshمشاهده پروفایل

استاد آموزشی

Northeastern UniversityUnited States

Lindsay Mehrmanesh is an Associate Teaching Professor at Northeastern University , affiliated with the Biology Project Laboratory . She integrates experiential learning and student-centered pedagogy to cultivate scientific identity among undergraduate researchers. PhD in Molecular Biology, Cell Biology, and Biochemistry from Brown University Her teaching philosophy prioritizes authentic research experiences , collaborative learning , and evidence-based mentorship . Beyond the classroom, she designs innovative undergraduate research programs and advocates for equity in STEM , particularly supporting first-generation students . While her current role emphasizes pedagogy, her scientific contributions span transcriptional regulation , reproductive biology , and epigenetic mechanisms , as evidenced by her Google Scholar publications from 2007–2020. Her interdisciplinary work bridges genetics , oncology , and developmental biology , with studies on genes like TAF4B in ovarian cancer and spermatogonial stem cell development. She has also contributed to biochemical systems like the MmeI restriction-modification enzyme . As a core instructor, she emphasizes scientific identity and equity initiatives . No specific scientific awards, grants, or student advising details are mentioned in her profile.

پروفایل رسمی دانشگاه

Gavin Knottمشاهده پروفایل

دانشیار

Monash UniversityAustralia

Gavin Knott is an Associate Professor in the Department of Biochemistry and Molecular Biology at Monash University, leading the Knott Lab within the Biomedicine Discovery Institute. His research focuses on RNA biology, CRISPR-Cas systems, and nucleic acid modification machinery. He obtained his Ph.D. from the University of Western Australia, followed by postdoctoral work at the University of California, Berkeley under Nobel laureate Jennifer Doudna. His lab employs multidisciplinary approaches spanning computational biology, biochemistry, and structural biology to develop next-generation biotech tools for diagnostics and therapeutics. Education: Ph.D. in Biochemistry (University of Western Australia, 2016) External Positions: Postdoctoral Fellow at UC Berkeley (2016–2021) Research interests include understanding RNA-binding proteins, CRISPR immune systems in microbes, and structural biology of nucleic acid-modifying enzymes. Key projects include developing CRISPR-based diagnostic tools (e.g., Cas13a for SARS-CoV-2 detection) and creating novel RNA manufacturing enzymes. Knott has secured grants like the NHMRC Investigator Grant (2020) and awards including the ASBMB Boomerang Award (2019). Recent articles highlight advancements in cryo-EM techniques, CRISPR enzyme classification (CasPEDIA database), and structural insights into CRISPR-Cas9 mechanisms. His team collaborates on initiatives like the Victorian Pre-clinical mRNA Innovation Incubator (VPMII), advancing RNA therapeutics. Scientific Awards: Sir Keith Murdoch Fellowship (2018) NHMRC Investigator Grant (2020) ASBMB Boomerang Award (2019) Lorne Protein Anders Young Investigator Award (2019) Knott actively contributes to academic activities, including organizing the CRISPR Conference 2025 and serving as a Guest Editor for Methods . His lab’s work aligns with UN Sustainable Development Goals related to health and innovation.

پروفایل رسمی دانشگاه

Stanley F. Nelsonمشاهده پروفایل

استاد

University of California, Los AngelesUnited States

Stanley F. Nelson is a Professor-in-residence at the University of California Los Angeles (UCLA), holding roles in the Department of Human Genetics, Pathology and Laboratory Medicine, Neurology, and Pediatrics. He leads research in genetic disorders, with a focus on undiagnosed diseases, exome sequencing, and genomic diagnostics. His work emphasizes rare diseases, neurodevelopmental disorders, and translational medicine. Dr. Nelson completed his BS in Physics from the University of Michigan (1982), MD from UCSF (1987), and postdoctoral training in Genomics at Stanford University (1993). He specializes in genomic technologies for identifying genetic causes of rare conditions, particularly through the Undiagnosed Diseases Network (UDN). His research integrates computational and experimental approaches to uncover genetic architectures of diseases like Duchenne muscular dystrophy, congenital diarrheas, and neurodegenerative disorders. His articles highlight advancements in exome sequencing, drug repositioning for muscular dystrophy, and molecular mechanisms of genetic disorders. He collaborates extensively with clinical and computational groups to bridge basic science and patient care. His contributions to diagnostic genomics have improved outcomes for patients with rare and undiagnosed conditions.

پروفایل رسمی دانشگاه

Lori Pileمشاهده پروفایل

استاد

Wayne State UniversityUnited States

Epigenetic Control of Gene Expression
Chromatin Structure and Gene Transcription
Cancer Biology
+۳ مورد دیگر

Lori Pile is a Professor and Associate Dean for Undergraduate Studies at Wayne State University's College of Liberal Arts and Sciences, affiliated with the Biological Sciences Department. Her research focuses on epigenetic control of gene expression, particularly investigating the SIN3 histone-modifying complex's role in chromatin structure and transcriptional regulation. She holds a Ph.D. in Molecular Genetics from the University of Cincinnati Medical School (1998). Education: Ph.D. in Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati Medical School, 1998 Her research addresses how genome packaging via histone modifications affects gene expression in development and disease, with applications to cancer and neurodegenerative disorders. Using Drosophila and human cancer models, her lab explores SIN3's role in epigenetic signaling cascades critical for cell proliferation and viability. Recent publications (2020-2025) highlight work linking SIN3 to metabolism, cancer metastasis, and neurodegenerative disease modeling. She teaches Science Advocacy and Public Engagement and has mentored lab alumni pursuing academic, industry, and medical careers.

پروفایل رسمی دانشگاه

Elisabeth Busch-Nentwichمشاهده پروفایل

مدرس ارشد

Queen Mary University of LondonUnited Kingdom

Dr. Elisabeth Busch-Nentwich is a Senior Lecturer in Organismal Biology at Queen Mary University of London, affiliated with the School of Biological and Behavioural Sciences. Her research focuses on gene regulatory responses to challenges such as genetic mutations, chromatin disruption, and infection, primarily using zebrafish as a model system. Her lab investigates molecular mechanisms underlying disease susceptibility, lipid metabolism, and developmental processes. Key research areas include understanding how genetic mutations impact cellular functions and host-pathogen interactions. She has supervised PhD students Pavol Kramár and Tian Qiu, and postdoctoral researchers Ian Sealy and Richard White. Recent work highlights her lab’s contributions to studying Shigella infection susceptibility, tumor suppression mechanisms in melanoma, and the role of selenoproteins in vascular disorders. Her publications reflect a strong emphasis on translational research, bridging fundamental biology with clinical implications. Dr. Busch-Nentwich’s lab, based in London, employs cutting-edge techniques such as single-cell RNA sequencing and CRISPR-mediated mutagenesis to dissect complex biological processes. Her work has implications for understanding metabolic diseases, genetic disorders, and infectious diseases.

پروفایل رسمی دانشگاه

Mélanie Hamonمشاهده پروفایل

پژوهشگر

Pasteur InstituteFrance

Mélanie Hamon is a Structure Manager at the Pasteur Institute leading the Chromatin and Infection research team within the Cell Biology and Infection department. Her work focuses on epigenetic mechanisms in host-pathogen interactions , particularly studying Listeria monocytogenes and Streptococcus pneumoniae infection models. 2024 Chair of Excellence awardee 2024 publication on S. pneumoniae epigenetic memory 2024 discovery of host-directed oxadiazole compounds for tuberculosis Her research explores how: Bacterial pathogens modify chromatin to manipulate host transcription Epigenetic immune memory develops after infections Host metabolic pathways support pathogen replication Membrane dynamics facilitate intracellular niche formation Post-translational histone modifications affect infection outcomes Key methodologies include ChIP-seq , CRISPR , and mass spectrometry , with recent publications (2024) showing: Epithelial cell memory mechanisms Zinc poisoning in host-directed therapy SNX8-RAB11A axis in vacuole rupture Collagen induction via plasma activation Scientific contributions include: Discovered SIRT2-TDP-43 interaction in 2021 Identified IAM subpopulation dynamics in 2024 Elucidated KDM6B's role in 2021 Current advisees: PhD student: Justine Matheau PhD student: Leonardo Gonzalez-Smith

پروفایل رسمی دانشگاه

Casey Giffordمشاهده پروفایل

استادیار

Stanford UniversityUnited States

Casey Gifford is an Assistant Professor of Pediatrics - Cardiology and Genetics at Stanford University School of Medicine . They are actively involved in research and teaching, with affiliations to multiple institutes including the Bio-X , Cardiovascular Institute , and Institute for Stem Cell Biology and Regenerative Medicine . PhD in Stem Cell Biology and Epigenomics from Harvard Medical School (2013) Postdoctoral Fellowship in Heart Development at Gladstone Institutes, UCSF (2019) Their research focuses on genetic and epigenetic mechanisms in cardiovascular development and disease, particularly congenital heart defects and gene regulatory networks . They use human induced pluripotent stem cell (iPSC) models , single-cell multiomic analysis , and CRISPR technology to investigate molecular pathways in cardiac development, fibroblast activation, and stress response. Recent publications highlight work on: Interferon signaling in thymic epithelial cell differentiation Mitochondrial variant pathogenicity in multisystem dysfunction Gene network convergence in valvular interstitial cells Mitochondrial-Nuclear incompatibility in hybrid species Transcription factor interactions (ISL1-NKX2.5) in cardiomyocyte fate They mentor graduate students in Genetics , Pediatric Cardiology , and Stem Cell Biology programs, and lead courses including Advanced Genetics and Stem Cell Intensive . Their lab contributes to the GREGoR Consortium for rare disease genomics and uses single-cell datasets to explore regulatory mechanisms in cardiac and craniofacial development.

پروفایل رسمی دانشگاه

Tülin Tatarمشاهده پروفایل

پژوهشگر ارشد

University of CopenhagenDenmark

Tülin Tatar is a Postdoctoral Research Fellow at the Helin Group, Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark. Her research focuses on epigenetic mechanisms in cancer biology and stem cell systems, with contact details including phone +4535326973 and email tulin.tatar@bric.ku.dk at Ole Maaløes Vej 5, 2200 København N. Her research interests center on epigenetic regulation , specifically histone modifications (H3K27 methylation/acetylation), Polycomb repressive complexes (PRC2), and signaling pathways in cancer and pluripotent stem cells. She employs advanced genomic and biochemical techniques to investigate how epigenetic machinery controls cell fate decisions, tumor progression, and therapeutic responses, with emphasis on targets like MPP8, TAK1, and RIPK1. Analysis of her publications reveals a cohesive research trajectory exploring epigenetic vulnerabilities in cancer and stem cell maintenance. Her work bridges fundamental chromatin biology with translational applications, particularly in immuno-oncology and regenerative medicine, demonstrating consistent contributions to high-impact journals including Nature Genetics and Molecular Cell . No scientific awards were documented in the provided information. While no student advising or grant details were specified, her collaborative publications indicate active participation in international research networks. Her work on TAK1 inhibition and PRC2 complex mechanics suggests ongoing exploration of targeted cancer therapies and epigenetic editing tools. Dr. Tatar operates within the Helin Group at BRIC, a premier biomedical research hub at the University of Copenhagen specializing in epigenetic mechanisms of development and disease. The group leverages cutting-edge CRISPR-based editing, multi-omics approaches, and disease modeling to advance understanding of chromatin dynamics in health and pathology.

پروفایل رسمی دانشگاه